Table 1.

Patient characteristics and target segments^†

Patient	Age (years)	Sex	Emphysema	FEV1 (L)	Targeted segment	Tumor size (mm)	Pathologic diagnosis	TNM stage
1	48	F	None	2.24	LS1 + 2 + 3	8	MIA	T1mi
2	52	M	None	2.57	RS2	10	MIA	T1mi
3	62	F	None	1.98	LS1 + 2	9	MIA	T1mi
4	65	F	None	2.12	LS6	7	AIS	0 (Tis)
5	36	F	None	2.44	RS1	8	AIS	0 (Tis)
6	59	M	None	2.96	LS1 + 2 + 3	15	IAC	IA2 (T 1bN0M0)
7	53	F	None	2.14	LS1 + 2	11	MIA	T1mi
8	64	F	None	1.75	LS6	14	IAC	IA2 (T 1bN0M0)
9	59	F	None	1.87	RS3	6	AAH	‐
10	33	M	None	4.12	LS4 + 5	9	IAC	IA1 (T 1aN0M0)
11	51	M	None	2.78	RS2	9	IAC	IA1 (T 1aN0M0)
12	38	F	None	2.45	LS1 + 2 + 3	11	Benign	‐
13	28	F	None	3.12	LS1 + 2 + 3	8	MIA	T1mi
14	58	F	None	2.02	RS6	9	MIA	T1mi
15	72	M	None	1.64	RS3	12	IAC	IA2 (T 1bN0M0)
16	43	F	None	2.41	LR1	8	MIA	T1mi
17	37	F	None	2.86	LS6	7	AIS	0 (Tis)
18	71	F	None	1.43	LS1 + 2	13	MIA	T1mi
19	32	M	None	3.42	RS2	8	Benign	‐
Mean	50.58 ± 13.71			2.44 ± 0.66		9.58 ± 2.28

^† Five males, 14 females. Right: S¹, apical segment; S², posterior segment; S³, anterior segment； S⁶, superior segment; Left: S^{1 + 2}, apico‐posterior segment; S³, anterior segment; S⁴, superior lingular segment; S⁵, inferior lingular segment; S⁶, superior segment; AAH, atypical adenomatous hyperplasia; AIS, adenocarcinoma in situ; FEV1, forced expiratory volume in one second; IAC, invasive adenocarcinoma; MIA, minimally invasive adenocarcinoma; TNM, tumor node metastasis; TNM, tumor node metastasis.